HeartLab

What HeartLab does

HeartLab is a New Zealand-headquartered, privately-held healthcare technology company that has built a cloud-native, browser-based cardiology imaging platform designed to replace legacy on-premise PACS systems. The platform supports multi-modality cardiac imaging including echocardiograms, stress echocardiograms, vascular ultrasound, nuclear cardiac testing, and CT imaging, with HL7 and DICOM connectivity to PMS, CVIS/RIS, and EHR/EMR systems, and Open APIs for downstream integration. It is sold on a subscription-plus-per-study-fee SaaS model across Flexi, Business, and Enterprise tiers, all of which include unlimited users and machines, automatic updates, and bundled support, with pricing quote-based and not publicly disclosed.

The company serves private cardiology practices, multi-site cardiology groups, and enterprise healthcare organisations across Australia, New Zealand, and the United States, with the United Kingdom identified as the next geographic expansion (London office announced February 2026, pending regulatory clearance). Distribution is direct enterprise field sales, augmented by presence at major cardiology conferences (ACC, CSANZ), with named customers including Cardio Vascular Services (10 clinics, ~15,000 echo studies/year), West Michigan Cardiology (3 offices, 9,000–10,000 studies/year), Victoria Heart, CardioLabs, Gippsland Cardiac Tech, and Strong Hearts. AI capabilities are delivered through partner integrations with Us2.ai, Ultromics, and InVision Medical Technology rather than proprietary models.

HeartLab operates through wholly-owned subsidiaries in New Zealand (primary entity HeartLab Limited), Australia (HeartLab Australia Pty Ltd, NSW), the United States (HeartLab, Inc., Delaware), and the United Kingdom (HeartLab UK Ltd, England and Wales). The company has disclosed approximately $3.38M in cumulative funding across NZ government grants and a 2021 seed round led by Founders Fund with Icehouse Ventures and Outset Ventures, and has not raised institutional capital since 2021. Leadership comprises CEO and founder Will Hewitt, CTO Richard Viney, CRO Matt Toulson (formerly of Hudl), and Head of Engineering Max Tuzzolino (formerly of Practiv).

Name

HeartLab

Legal name

HeartLab Limited

Website

https://heartlab.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

HeartLab provides a cloud-native, browser-based cardiology imaging platform that replaces legacy on-premise PACS for private cardiology practices, multi-site groups, and enterprise healthcare organisations across Australia, New Zealand, and the United States, with the United Kingdom entering expansion.

Ownership category

akta.pro rank

Product category

Cardiology Imaging Software

NAICS

Computer Systems Design and Related Services (54151)

SIC

Services-Health Services (8000)

akta.pro primary industry

Picture Archiving & Communication Systems (PACS) (HLACALAA)

akta.pro secondary industries

Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD), Radiology Reporting, Dictation & Structured Reporting (HLACALAF), Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web) (HLACALAI), Teleradiology Platforms & Reading Workflow (HLACALAK), Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE) (HLACALAJ)

Keywords

• Cardiology imaging software
• Cloud PACS platform
• Echocardiogram reporting
• Cardiac imaging SaaS
• Medical imaging PACS

Headquarters

HQ city

Auckland

HQ country

New Zealand

HQ region

Oceania

Offices5 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Subscription - Monthly recurring: HeartLab operates on a subscription (SaaS) model charging a monthly subscription fee together with a per study fee. All plans include unlimited users and unlimited machines. Subscriptions include automatic updates, new features, maintenance, and support at no additional cost. For small to medium practices, customers are typically up and running within days. The pricing model is designed to be accessible to clinics of all sizes.
2. Per Study fee (usage-based): In addition to the monthly subscription, HeartLab charges a per study fee. Customers have a Minimum Study Allocation in their contract for which they are charged regardless of actual study count. Studies exceeding the minimum are charged at the per study rate. This usage-based component allows clinics of all sizes to access cloud-based innovation while paying in proportion to their volume.
3. Additional storage fees: Customers have a defined Storage Limit in their Order Form. If they store data beyond the Storage Limit, additional Charges may be imposed based on then-current rates. Additional storage beyond contracted limits can be added via a new Order Form.
4. Additional Services / Statement of Work: HeartLab may provide Additional Services such as consulting services as specified in a Statement of Work (SOW). These are charged separately at rates set out in the SOW, including reasonable out-of-pocket expenses.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

HeartLab is a cloud-native, browser-based cardiology imaging PACS (Picture Archiving and Communication System) platform that provides secure viewing, reporting, and analysis of cardiac imaging studies (echocardiograms, stress echocardiograms, vascular ultrasound, nuclear cardiac testing, and CT imaging) from most connected devices. It replaces legacy on-premise cardiology PACS with a vendor-neutral, multi-tenanted SaaS solution supporting DICOM and HL7 connectivity, native AI integrations, customizable report templates, and real-time remote collaboration for cardiologists and sonographers.

Product overview

HeartLab offers a single cloud-native cardiology imaging platform designed to replace legacy on-premise PACS systems. The core HeartLab Cardiology Imaging Platform provides cloud-based viewing, reporting, and analysis of cardiac imaging studies (echocardiograms, stress echocardiograms, vascular ultrasound, nuclear cardiac testing, and CT imaging) accessible from any connected device. The platform integrates native AI capabilities through partnerships with Us2.ai and Ultromics. HeartLab also announced a partnership with InVision Medical Technology to bring AI-based detection of cardiac amyloidosis and heart function assessment to Australia & New Zealand (pending regulatory approval). Pricing is subscription-based with per-study fees, available in Flexi, Business, and Enterprise tiers with unlimited users and machines.

Differentiator

Problem solved

Functional benefit

Products and services

• HeartLab Cardiology Imaging Platform Cloud-native, browser-based cardiology PACS platform providing secure viewing, reporting, and analysis of cardiac imaging studies (echocardiograms, stress echocardiograms, vascular ultrasound, nuclear cardiac testing, and CT imaging). Designed for cardiology practices, hospitals, and enterprise healthcare organisations, replacing legacy on-premise PACS with a vendor-neutral, multi-tenanted SaaS solution. Includes native HL7/DICOM connectivity, Open APIs, automated measurements, customizable report templates, real-time collaboration, and integrations with AI partners (Us2.ai, Ultromics, InVision).
• HeartLab Professional Services (Statement of Work) Additional consulting and bespoke implementation services delivered under Statement of Work (SOW) agreements, including Business and Enterprise onboarding sessions, report template customisation, best-practice consulting, and reimbursement of reasonable out-of-pocket expenses. Sold separately at rates set out in the SOW for HeartLab customers requiring bespoke engagement beyond standard subscription onboarding.

Quantifiable outcome

• West Michigan Cardiology saves at least 10 minutes per study through automated measurements, with each of four sonographers gaining approximately one hour back per day (over an hour total daily across the practice).
• +4 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability6 records

Feature12 records

Partnerships

Five partnerships are on record, tiered core and minor.

• InVision Medical TechnologycoreTechnology or Integration · 13 October 2025HeartLab has partnered with InVision Medical Technology to bring its AI algorithms to Australia and New Zealand. InVision develops AI tools to streamline interpretation of heart ultrasounds and identify undiagnosed disease. The partnership will make available AI-based detection of cardiac amyloidosis and assessment of heart function (Precision LVEF) for early detection and treatment of heart failure. This is the first time this technology is available in the region. The technology will become available pending regulatory approval, expected in H1 2026. InVision's Precision Cardiac Amyloid and Precision LVEF is already FDA cleared in the United States.
• Us2.aicoreTechnology or IntegrationNative AI integration with Us2.ai, providing AI-based echocardiogram analysis capabilities within the HeartLab platform. Us2.ai is listed as one of the partner companies providing AI integrations as part of the HeartLab platform's feature set.
• UltromicscoreTechnology or IntegrationNative AI integration with Ultromics, providing AI-based echocardiogram analysis capabilities within the HeartLab platform. Ultromics is listed as one of the partner companies providing AI integrations as part of the HeartLab platform's feature set.
• Echo GuruminorStrategic or Co-development PartnerHeartLab partnered with Echo Guru (Tony Forshaw) for the CSANZ 2025 conference, hosting a 'Bites and QI Insights' lunchtime QI session at Stand 29. The collaboration included the HeartLab & Echo Guru QI Challenge — a hands-on skills competition for echo lab professionals, with prizes including Apple AirPods and 12-month Echo Chamber Premium Membership.
• Amazon Web Services (AWS)coreTechnology or IntegrationAWS is the primary cloud infrastructure provider, hosting HeartLab's platform in the eu-west-2 (London) region. AWS provides database hosting, S3 storage, and compute (Lambda, Fargate, ECS) for processing and storing all patient/clinical data. AWS is a sub-processor under HeartLab's Data Processing Agreement.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Lumedx: Cardiovascular information system (CVIS) vendor focused on cardiology workflows, reporting, and image management. Overlaps with HeartLab's cardiology PACS and structured reporting capabilities.
• ScImage: Offers cloud-based enterprise imaging and PACS with a cardiology-focused offering (PicomCardio), directly competing with HeartLab for multi-site cardiology groups and hospital cardiology departments.
• Change Healthcare Cardiology (Optum): Provides cardiology PACS and imaging workflow solutions to hospitals and cardiology practices in the same customer base as HeartLab. Now part of Optum, it is a primary incumbent competitor in cardiology imaging informatics.
• Circle Cardiovascular Imaging: Specializes in cardiovascular imaging post-processing and viewing for CMR, CCT, and echo, serving cardiology practices and hospitals globally. Competes in the same cardiovascular imaging analytics niche as HeartLab.

Broad incumbents

• GE Healthcare Centricity/Cardiolab: GE's cardiology imaging and reporting solutions, including EchoPAC, compete in cardiology PACS and reporting. Provides an incumbent alternative that customers may already own alongside GE imaging equipment.
• Philips IntelliSpace Cardiovascular: Enterprise cardiology imaging and analytics suite from a global imaging equipment incumbent. Competes broadly in the same cardiology imaging informatics market as HeartLab, typically bundled with Philips echo/CT hardware.
• Siemens Healthineers syngo.via: Multi-modality imaging IT platform with cardiovascular capabilities from a global imaging equipment leader. Overlaps with HeartLab in cardiology viewing, reporting, and multi-modality imaging workflows.
• FUJIFILM Synapse Cardiology: FUJIFILM's cardiology PACS and enterprise imaging portfolio directly competes in cardiology image management, particularly for hospital and large-practice customers.

Emerging players

• Us2.ai: AI echocardiography analysis partner of HeartLab that also pursues direct sales to cardiology practices. Comparable as an emerging AI echo player with overlapping clinical use cases and customer base.
• Viz.ai (Cardiology Suite): AI-driven cardiology workflow platform (extending from its neurology origins) targeting cardiology detection and care coordination. Comparable as an emerging AI cardiology workflow vendor serving similar clinical users.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/heartlabai

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries3 records

Funding overview

Funding rounds6 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HeartLab